1. Home
  2. STXS vs PFO Comparison

STXS vs PFO Comparison

Compare STXS & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • PFO
  • Stock Information
  • Founded
  • STXS 1990
  • PFO 1991
  • Country
  • STXS United States
  • PFO United States
  • Employees
  • STXS N/A
  • PFO N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PFO Finance Companies
  • Sector
  • STXS Health Care
  • PFO Finance
  • Exchange
  • STXS Nasdaq
  • PFO Nasdaq
  • Market Cap
  • STXS 151.3M
  • PFO 121.4M
  • IPO Year
  • STXS 2004
  • PFO N/A
  • Fundamental
  • Price
  • STXS $2.90
  • PFO $9.31
  • Analyst Decision
  • STXS
  • PFO
  • Analyst Count
  • STXS 0
  • PFO 0
  • Target Price
  • STXS N/A
  • PFO N/A
  • AVG Volume (30 Days)
  • STXS 546.0K
  • PFO 31.8K
  • Earning Date
  • STXS 08-07-2025
  • PFO 01-01-0001
  • Dividend Yield
  • STXS N/A
  • PFO 6.51%
  • EPS Growth
  • STXS N/A
  • PFO N/A
  • EPS
  • STXS N/A
  • PFO N/A
  • Revenue
  • STXS $31,806,000.00
  • PFO N/A
  • Revenue This Year
  • STXS $29.03
  • PFO N/A
  • Revenue Next Year
  • STXS $44.05
  • PFO N/A
  • P/E Ratio
  • STXS N/A
  • PFO N/A
  • Revenue Growth
  • STXS 33.94
  • PFO N/A
  • 52 Week Low
  • STXS $1.54
  • PFO $6.90
  • 52 Week High
  • STXS $3.05
  • PFO $8.51
  • Technical
  • Relative Strength Index (RSI)
  • STXS 61.19
  • PFO 57.88
  • Support Level
  • STXS $2.81
  • PFO $9.19
  • Resistance Level
  • STXS $2.91
  • PFO $9.31
  • Average True Range (ATR)
  • STXS 0.15
  • PFO 0.05
  • MACD
  • STXS -0.00
  • PFO -0.00
  • Stochastic Oscillator
  • STXS 60.78
  • PFO 70.59

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: